ask="4.49"
ask_size="400"
average_daily_volume="296463"
bid="2.15"
bid_size="100"
book_value="3.30"
change="-0.15"
change_from_200_day_moving_average="1.00"
change_from_50_day_moving_average="-0.17"
change_from_52_week_high="-6.97"
change_From_52_week_low="0.52"
change_in_percent="-3.61%"
close="4.01"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-3.13"
ebitda="-44.46M"
eps_estimate_current_year="5.02"
eps_estimate_next_quarter="-0.35"
eps_estimate_next_year="5.28"
ex_dividend_date="N/A"
float_shares="13906000"
high="4.20"
high_52_weeks="10.98"
last_trade_date="3/15/2017"
last_trade_price="4.01"
last_trade_size="3140"
last_trade_time="4:00pm"
low="4.00"
low_52_weeks="3.49"
market_capitalization="90.47M"
moving_average_200_day="3.01"
moving_average_50_day="4.18"
name="Cascadian Therapeutics
Inc."
notes="N/A"
one_year_target_price="390.00"
open="4.17"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+33.22%"
percent_change_from_50_day_moving_average="-4.17%"
percent_change_from_52_week_high="-63.48%"
percent_change_from_52_week_low="+14.90%"
previous_close="4.16"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.26"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="22562000"
short_ratio="3.80"
stock_exchange="NMS"
symbol="CASC"
volume="110960"
weeks_range_52="3.49 - 10.98"
